Summit X’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Summit X's GILD Position: Q3 2025 in Review
Summit X sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 21,499 shares — an estimated $2.38M sold.
Summit X first reported a position in GILD in Q2 2017 and held it in 25 quarters. The position peaked at $2.57M in Q4 2019. 2,040 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Summit X reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Summit X sold 21,499 Gilead Sciences shares in Q3 2025, an estimated $2.38M.
- Summit X first reported a position in Gilead Sciences in Q2 2017 and held it in 25 quarters.
- Summit X's Gilead Sciences position peaked at $2.57M in Q4 2019.
- 2,040 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Summit X's 13F filing for Q3 2025.